Lynn Dorsey Bleil is of AMICUS THERAPEUTICS, INC.. Currently has a direct ownership of 93,527 shares of FOLD, which is worth approximately $903,470. The most recent transaction as insider was on Jun 06, 2024, when has been sold 11,847 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.5K
0% 3M change
14.5% 12M change
Total Value Held $903,470

Lynn Dorsey Bleil Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 06 2024
BUY
Grant, award, or other acquisition
-
11,847 Added 11.24%
93,527 Common Stock
Jun 08 2023
BUY
Grant, award, or other acquisition
-
8,584 Added 9.51%
81,680 Common Stock
Jun 09 2022
BUY
Grant, award, or other acquisition
-
12,671 Added 14.77%
73,096 Common Stock
Jun 10 2021
BUY
Grant, award, or other acquisition
-
10,115 Added 14.34%
60,425 Common Stock
May 25 2021
BUY
Open market or private purchase
$250,008 $8.74 p/Share
28,605 Added 36.25%
50,310 Common Stock

Also insider at

SRCL
STERICYCLE INC Industrials
LDB

Lynn Dorsey Bleil

Bannockburn, IL

Track Institutional and Insider Activities on FOLD

Follow AMICUS THERAPEUTICS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FOLD shares.

Notify only if

Insider Trading

Get notified when an Amicus Therapeutics, Inc. insider buys or sells FOLD shares.

Notify only if

News

Receive news related to AMICUS THERAPEUTICS, INC.

Track Activities on FOLD